Business Wire

AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia

Share

Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) announced today that the European Medicines Agency (EMA) has approved bluebird bio’s application for Conditional Marketing Authorization (cMAA) of their product Zynteglo™, a gene therapy for the treatment of adolescents and adults with transfusion-dependent β-thalassaemia (TDT) who do not have a β00 genotype.

As a result of this marketing authorisation, Zynteglo™ is now approved for use in all European countries covered by the European Medicines Agency.

Zynteglo™ has been given ‘conditional authorisation’. This means that there is more evidence to be submitted, which the company is required to provide under specific obligations. Every year, the EMA will review any new information that becomes available.

“People living with transfusion-dependent β-thalassaemia have a reduced life expectancy, requiring life-long frequent blood transfusions that are life-saving but may lead to complications, including organ failure due to iron overload,” said Dr. Michele Lipucci di Paola, of AVLT, patient representative at EMA.

Dr. Chris Sotirelis, an expert patient at EMA said: “The approval of Zynteglo™ is a breakthrough that offers a unique treatment choice to patients, as the first one-time gene therapy that addresses the underlying genetic cause of transfusion-dependent β-thalassaemia.

The opinion adopted by the CHMP at its March 2019 meeting is an intermediary step for Zynteglo™ to path to reach patients. The CHMP opinion, once confirmed by the European Commission, will result in an EU-wide marketing authorisation. After that decisions about price and reimbursement will take place at the level of each Member State, taking into account the potential role/use of this medicine in the context of the national health system of that country.

Contact information

AVLT
Dr. Michele Lipucci di Paola
+39 3382104475
mlipucci@yahoo.com

UKTS
Dr. Chris Sotirelis
+44 7979594067
chris.sotirelis@gmail.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Wildz Casino Leads the Way in iGaming Machine Learning and Automation16.7.2019 09:00:00 CESTPress release

As iGaming continues to expand into new global markets, Wildz Casino has entered the game at a time when innovation and ‘Machine Learning’ are emerging as dominant factors in this industry. Powered by a Rootz platform allowing for full automation, early signs are promising. Optimisation based on customer preferences has increased player value by 27% with streamlined, automated processes improving efficiency in all facets of the business. In today’s iGaming industry, it appears the innovative team behind Wildz.com are leading the charge into a ‘Machine Learning’ assisted future. By 2025, the global AI market is projected to be valued at almost $60 billion compared to $1.4 billion just a few years ago. Compared to competitors, Wildz has entered the market early. The result? A perfectly functioning machine, easy on the eye, with superb player incentives and an unrivalled Loyalty+ programme. Wildz by Rootz is powering Machine Learning and Automation into the iGaming future. Learn more abou

LifeSpan BioSciences Announces the Acquisition of Everest Biotech16.7.2019 08:00:00 CESTPress release

LifeSpan BioSciences (LSBio™), a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Everest Biotech. Everest Biotech are ISO 9001:2015 certified experts in antigen affinity purified goat polyclonal antibodies. The acquisition of Everest Biotech further expands LSBio’s product offering and strengthens the company’s position as one of the fastest growing providers in the research reagent market. Through its partnerships, LSBio now offers a comprehensive catalogue of reagents that can be coupled with their extensive collection of IHC validated primary antibodies. “We are looking forward to adding the Everest Biotech product range to the LSBio portfolio,” said Heather Holemon, CEO of LSBio. “Everest Biotech products are of exceptionally high quality and perfectly complement our existing portfolio.” The Everest Biotech commitment to quality and continuous improvement has ensured the growth of their catalogue, which now contains thous

AppyParking Closes £7.6 Million Series A Funding16.7.2019 07:00:00 CESTPress release

AppyParking, the kerbside management and mobility technology firm that is transforming parking for motorists and empowering local authorities and car park operators to better manage their assets, announced that the company has just closed a £7.6 million Series A round. The funding round includes new strategic investment from Hyundai Motor Company and Sumitomo Corporation. It was led by West Hill Capital, the London based venture capital firm, with participation from existing investors Aviva Ventures and Breed Reply. The investment brings AppyParking’s total funding since launch to over £11 million and will enable the company to accelerate product development, support domestic and international growth and continue to expand their talented team. Founded in 2013 with the launch of their award-winning smart parking app, AppyParking is on a mission to make parking forgettable and help prepare cities for the rise of autonomous vehicles. They were the first company in the world to focus on th

Dubai to Organise Global Investment in Aviation Summit in January 202016.7.2019 07:00:00 CESTPress release

The General Civil Aviation Authority (GCAA) of UAE has announced that the second edition of Global Investment in Aviation Summit (GIAS) 2020, themed ‘Enabling Global Aviation Growth through Fund Raising and Key Partnerships’ will be held in Dubai from January 27-29. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190716005136/en/ Saif Mohammed Al Suwaidi, Director General of the GCAA (Photo: AETOSWire) Over 200 investors and 1,200 delegates, besides selected government officials, aviation organisations, finance & insurance firms, aviation asset owners, aircraft operators & logistic service providers and legal consultants are expected to turn up at the event. While disclosing the details of the summit Saif Mohammed Al Suwaidi, Director General of the GCAA, highlighted the UAE’s remarkable position in the international and regional aviation industry. Al Suwaidi said, “The national agenda for 2021 aims for UAE to be the world fi

Our Toy Stories @ Harbour City16.7.2019 02:13:00 CESTPress release

While Disney and Pixar’s “Toy Story 4” is hitting the big screens around the world this summer, Harbour City, the largest shopping mall in Hong Kong, is joining forces with Disney to bring the movie to life from now till 4 August, 2019! Inspired by the movie, Harbour City has transformed into a “Toy Story” themed carnival with different games and challenges at Ocean Terminal Forecourt next to Star Ferry Pier and Ocean Terminal Deck with stunning Victoria Harbour view, where fans can play with Woody and the gang under the best Harbour & Sunset views in Hong Kong! This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005854/en/ Large Scale Toy Story Carnival at Harbour City in Hong Kong (Photo: Business Wire) Additionally, fans can experience other fun, immersive activities throughout the mall including The Art of Toy Story 4 exhibit, kids’ workshops, “Toy Story 4” pop-up store, along with a “Toy Story” themed dessert pop-up st

HSEVEN Accelerate World-Class African Startups16.7.2019 01:00:00 CESTPress release

HSEVEN, Africa’s largest accelerator is launching “HSEVEN DISRUPT AFRICA”, an ambitious startup acceleration program designed for entrepreneurs of the Moroccan and African diaspora. The 6-month program will provide a seed investment of €150,000 plus an eventual investment of €500,000 to €1.5 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005770/en/ HSEVEN team (Photo: AETOSWire) HSEVEN DISRUPT AFRICA is designed to support exceptional entrepreneurs building high-impact startups, and targets seed and early stage startups with 2 to 5 founders that are eager to impact Africa through innovative services, products and business models. The program will start with a global call for applications, followed by an international selection roadshow in New York, Montréal, San Francisco, Shanghai, Dubaï, Londres, Amsterdam, Paris, Casablanca. The selected startups will benefit from a seed investment of €150,000 at the beginn